Amanote Research

Amanote Research

    RegisterSign In

Expression of COX-2 and Steroid Converting Enzymes in Breast Cancer

Oncology Reports - Greece
doi 10.3892/or.16.2.219
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineCancer ResearchOncology
Date

August 1, 2006

Authors
Cecilia GunnarssonAgneta JanssonBirgitta HolmlundLilianne FerraudBo NordenskjöldLars RutqvistLambert SkoogOlle Stål
Publisher

Spandidos Publications


Related search

HPV16 E7 Increases COX‑2 Expression and Promotes the Proliferation of Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Over-Expression of COX-2 mRNA in Colorectal Cancer

BMC Gastroenterology
MedicineGastroenterology
2014English

COX-2 Involvement in Breast Cancer Metastasis to Bone

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Novel COX-2 Inhibitor for Breast Cancer Therapy

2003English

Overexpression of COX-2 in Celecoxib-Resistant Breast Cancer Cell Lines

Journal of Surgical Research
Surgery
2010English

COX-2 Expression Predicts Worse Breast Cancer Prognosis and Does Not Modify the Association With Aspirin

Breast Cancer Research and Treatment
Cancer ResearchOncology
2011English

Prognostic Significance of Deiodinase Enzymes Mrna Expression in Breast Cancer

Journal of Evidence Based Medicine and Healthcare
2019English

Stromal, Rather Than Epithelial Cyclooxygenase-2 (COX-2) Expression Is Associated With Overall Survival of Breast Cancer Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

COX-2 Expression in Ovarian Cancer: An Updated Meta-Analysis

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy